Design, synthesis, molecular docking and in vitro anticancer activities of 1-(4-(benzamido)phenyl)-3-arylurea

Prafulla Sabale1, Nusrat Sayyad1, Abuzer Ali2

  • 1Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University Mahatma Jyotiba Fuley Shaikshanik Parisar Nagpur-440033 India prafullasable@yahoo.com nusratsayyad11@gmail.com +919158537050.

RSC Advances
|July 30, 2024
PubMed

Insights

Novel 1-(4-(benzamido)phenyl)-3-arylurea derivatives were designed as potential aromatase inhibitors for breast cancer therapy. Compound 6g demonstrated significant antitumor activity, showing promise as a new class of anticancer agents.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Biochemistry

Background:

  • Estrogens are critical in breast cancer development for both premenopausal and postmenopausal women.
  • Aromatase enzyme, crucial for estrogen biosynthesis, is a key therapeutic target.

Purpose of the Study:

  • To design and evaluate novel 1-(4-(benzamido)phenyl)-3-arylurea derivatives as potential aromatase inhibitors.
  • To identify potent compounds for breast cancer treatment targeting aromatase.

Main Methods:

  • Molecular docking simulations to identify lead compounds.
  • Synthesis and structural confirmation using spectroscopic techniques.
  • Cytotoxicity assessment via MTT assay against various cancer cell lines.
  • In silico prediction of physicochemical and ADMET properties.

Main Results:

  • Compound 6g exhibited a strong binding energy (-8.6 kcal mol⁻¹) with aromatase (3s7s), interacting with key residues.
  • Compound 6g displayed potent GI₅₀ values across multiple cancer cell lines (e.g., 11.35 μM for MDAMB-231).
  • Predicted physicochemical and ADMET properties suggest favorable drug-likeness for compound 6g.

Conclusions:

  • 1-(4-(benzamido)phenyl)-3-arylureas represent a promising new class of aromatase inhibitors.
  • Compound 6g shows significant potential as an antitumor agent, warranting further investigation for broader-spectrum anticancer drug development.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
689
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.7K
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Overview01:07

Preparation of 1° Amines: Hofmann and Curtius Rearrangement Overview

In the presence of an aqueous base and a halogen, primary amides can lose the carbonyl (as carbon dioxide) and undergo rearrangement to form primary amines. This reaction, called the Hofmann rearrangement, can produce primary amines (aryl and alkyl) in high yields without contamination by secondary and tertiary amines.
3.2K
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.0K
Preparation of 1° Amines: Azide Synthesis01:22

Preparation of 1° Amines: Azide Synthesis

Direct alkylation of ammonia produces polyalkylated amines, along with a quaternary ammonium salt. To exclusively prepare primary amines, the azide synthesis method can be used.
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
3.9K